Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian R Murphy

Showing results (91-100 of 122) with videos related to

Pageof 13
Sort By:
Vaccine|October 28, 2009
A novel human parainfluenza virus type 1 (HPIV1) with separated P and C genes is useful for generating C gene mutants for evaluation as live-attenuated virus vaccine candidatesEmmalene J Bartlett, Ann-Marie Cruz, Jim Boonyaratanakornkit, et al.
Journal of Virology|December 28, 2002
Determinants of the host range restriction of replication of bovine parainfluenza virus type 3 in rhesus monkeys are polygenicMario H Skiadopoulos, Alexander C Schmidt, Jeffrey M Riggs, et al.
Journal of Virology|April 13, 2007
Successful topical respiratory tract immunization of primates against Ebola virusAlexander Bukreyev, Pierre E Rollin, Mallory K Tate, et al.
Journal of Virology|January 30, 2004
Generation of recombinant human parainfluenza virus type 1 vaccine candidates by importation of temperature-sensitive and attenuating mutations from heterologous paramyxovirusesJason T Newman, Jeffrey M Riggs, Sonja R Surman, et al.
Journal of Virology|March 21, 2008
Comparative neuropathogenesis and neurovirulence of attenuated flaviviruses in nonhuman primatesOlga A Maximova, Jerrold M Ward, David M Asher, et al.
Journal of Virology|May 14, 2005
Deletion of M2 gene open reading frames 1 and 2 of human metapneumovirus: effects on RNA synthesis, attenuation, and immunogenicityUrsula J Buchholz, Stéphane Biacchesi, Quynh N Pham, et al.
Lancet (London, England)|June 29, 2004
Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARSAlexander Bukreyev, Elaine W Lamirande, Ursula J Buchholz, et al.
Virology|December 9, 2009
Human parainfluenza virus type 2 V protein inhibits interferon production and signaling and is required for replication in non-human primatesAnne Schaap-Nutt, Christopher D'Angelo, Margaret A Scull, et al.
Journal of the Pediatric Infectious Diseases Society|November 20, 2015
Evaluation of a Live-Attenuated Human Parainfluenza Type 1 Vaccine in Adults and ChildrenRuth A Karron, Jocelyn San Mateo, Bhagvanji Thumar, et al.
Virology|June 6, 2006
Attenuating mutations in the P/C gene of human parainfluenza virus type 1 (HPIV1) vaccine candidates abrogate the inhibition of both induction and signaling of type I interferon (IFN) by wild-type HPIV1William Van Cleve, Emerito Amaro-Carambot, Sonja R Surman, et al.
Pageof 13

Showing results (91-100 of 122) with videos related to

Sort By:
Pageof 13
Vaccine|October 28, 2009
A novel human parainfluenza virus type 1 (HPIV1) with separated P and C genes is useful for generating C gene mutants for evaluation as live-attenuated virus vaccine candidatesEmmalene J Bartlett, Ann-Marie Cruz, Jim Boonyaratanakornkit, et al.
Journal of Virology|December 28, 2002
Determinants of the host range restriction of replication of bovine parainfluenza virus type 3 in rhesus monkeys are polygenicMario H Skiadopoulos, Alexander C Schmidt, Jeffrey M Riggs, et al.
Journal of Virology|April 13, 2007
Successful topical respiratory tract immunization of primates against Ebola virusAlexander Bukreyev, Pierre E Rollin, Mallory K Tate, et al.
Journal of Virology|January 30, 2004
Generation of recombinant human parainfluenza virus type 1 vaccine candidates by importation of temperature-sensitive and attenuating mutations from heterologous paramyxovirusesJason T Newman, Jeffrey M Riggs, Sonja R Surman, et al.
Journal of Virology|March 21, 2008
Comparative neuropathogenesis and neurovirulence of attenuated flaviviruses in nonhuman primatesOlga A Maximova, Jerrold M Ward, David M Asher, et al.
Journal of Virology|May 14, 2005
Deletion of M2 gene open reading frames 1 and 2 of human metapneumovirus: effects on RNA synthesis, attenuation, and immunogenicityUrsula J Buchholz, Stéphane Biacchesi, Quynh N Pham, et al.
Lancet (London, England)|June 29, 2004
Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARSAlexander Bukreyev, Elaine W Lamirande, Ursula J Buchholz, et al.
Virology|December 9, 2009
Human parainfluenza virus type 2 V protein inhibits interferon production and signaling and is required for replication in non-human primatesAnne Schaap-Nutt, Christopher D'Angelo, Margaret A Scull, et al.
Journal of the Pediatric Infectious Diseases Society|November 20, 2015
Evaluation of a Live-Attenuated Human Parainfluenza Type 1 Vaccine in Adults and ChildrenRuth A Karron, Jocelyn San Mateo, Bhagvanji Thumar, et al.
Virology|June 6, 2006
Attenuating mutations in the P/C gene of human parainfluenza virus type 1 (HPIV1) vaccine candidates abrogate the inhibition of both induction and signaling of type I interferon (IFN) by wild-type HPIV1William Van Cleve, Emerito Amaro-Carambot, Sonja R Surman, et al.
Pageof 13